Patent details

EP1996238 Title: Chimeric Adenoviral Vectors and dsRNA as TLR3 Agonist

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP1996238
WO Application Number:
US2007005386
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP07752109.4
WO Publication Number:
WO2007100908
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:

Dates

Filing date:
28/02/2007
Grant date:
06/04/2016
EP Publication Date:
03/12/2008
WO Publication Date:
07/09/2007
Claims Translations Received Date:
Claims Translation B1 Received Date:
09/06/2016
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
06/04/2016
EP B1 Publication Date:
06/04/2016
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
27/02/2027
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
06/04/2016
 
 

 

Name:
Vaxart, Inc.
Address:
600 Townsend Street Suite 120E, San Francisco, CA 94103, United States of America (US)

Domicile Holder

Name:
ir. M.F.J.M. Ketelaars c.s.
From:
09/06/2016
Address:
NLO Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:

Inventor

Name:
TUCKER, Sean, N.
Address:
San Francisco, California 94131, United States of America (US)

Priority

1

Priority Patent Number:
848195 P
Priority Date:
28/09/2006
Priority Country:
United States of America (US)

2

Priority Patent Number:
846658 P
Priority Date:
22/09/2006
Priority Country:
United States of America (US)

3

Priority Patent Number:
821492 P
Priority Date:
04/08/2006
Priority Country:
United States of America (US)

4

Priority Patent Number:
802992 P
Priority Date:
22/05/2006
Priority Country:
United States of America (US)

5

Priority Patent Number:
801645 P
Priority Date:
19/05/2006
Priority Country:
United States of America (US)

6

Priority Patent Number:
778026 P
Priority Date:
28/02/2006
Priority Country:
United States of America (US)

Classification

IPC or IDT classification:
A61K 39/39; A61K 48/00; C07H 21/00; C07H 21/02; C07H 21/04; C12N 15/63;

Publication

Bulletin

1

Bulletin Heading:
EP3
Journal edition number:
26/16
Publication date:
29/06/2016
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

2

Bulletin Heading:
EP2
Journal edition number:
14/16
Publication date:
06/04/2016
Description:
European patents granted for the Netherlands

European Patent Bulletin

Issue number:
201614
Publication date:
06/04/2016
Description:
Grant (B1)

Annual Fee

Annual Fee(s) Due Date:
28/02/2026
Annual Fee Number:
20
Annual Fee Amount:
1400 Euro
Last Annual Payment Date:
07/01/2025
Last Annual Fee Paid Number:
19
Last Annual Fee Paid Amount:
1300 Euro
Payer:
Computer Patent Annuities Limited (CPA)
Filing date Document type Document Description Number of pages File Type
29/06/2016 Outgoing Correspondence Outgoing Letter 1 PDF /3/0/2/3/4/0800043203/docs/ep07752109.4_3_65375l271.pdf
09/06/2016 Incoming Correspondence Electronic Accompanying letter incoming document 2 PDF /3/0/2/3/4/0800043203/docs/ep07752109.4_0_incomingcorrespondenceelectronic20160609151046527.pdf
09/06/2016 Claims Translated claims 3 PDF /3/0/2/3/4/0800043203/docs/ep07752109.4_1_claims20160609151045857.pdf
09/06/2016 Outgoing Correspondence Outgoing Letter 1 PDF /3/0/2/3/4/0800043203/docs/ep07752109.4_2_outgoingcorrespondence20160609151045286.pdf